BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/2/2023 5:21:23 AM | Browse: 75 | Download: 119
Publication Name World Journal of Clinical Cases
Manuscript ID 81204
Country/Territory France
Category Oncology
Manuscript Type Case Report
Article Title Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report
Manuscript Source Unsolicited Manuscript
All Author List Moinard-Butot Fabien, Poprawa Elodie, Schohn Anna, Pietro Addeo and Benabdelghani Meher
Funding Agency and Grant Number
Corresponding Author Moinard-Butot Fabien, MD, Doctor, Department of Medical Oncology, Institut de Cancérologie Strasbourg Europe, 17 Rue Albert Calmette, Strasbourg 67200, France. f.moinard-butot@icans.eu
Key Words Gemcitabine; Pancreatic cancer; Peripheral vascular disease; Prolonged tumor response; Case report
Core Tip Gemcitabine is known for vascular side effect. In this case, we report a vascular acrosyndrome that occurred during first-line with Gemcitabine for pancreatic adenocarcinoma. In this case, the patient experienced prolonged tumor response. Immunological phenomena could be responsible for this double effect.
Citation Fabien MB, Elodie P, Anna S, Addeo P, Meher B. Gemcitabine-induced peripheral vascular disease and prolonged response in a patient with metastatic pancreatic adenocarcinoma: A case report. World J Clin Cases 2023; 11(6): 1372-1378
Received
2022-10-29 14:32
Peer-Review Started
2022-10-29 14:33
To Make the First Decision
Return for Revision
2023-01-12 00:54
Revised
2023-01-17 21:34
Second Decision
2023-02-01 03:14
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2023-02-02 05:21
Articles in Press
2023-02-02 05:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2023-02-09 07:19
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com